Two Distinct Characteristics of Immune Microenvironment in Human Hepatocellular Carcinoma with Wnt/β-Catenin Mutations
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Two Distinct Characteristics of Immune Microenvironment in Human Hepatocellular Carcinoma with Wnt/β-Catenin Mutations
Authors
Keywords
-
Journal
Liver Cancer
Volume -, Issue -, Pages 1-21
Publisher
S. Karger AG
Online
2023-10-12
DOI
10.1159/000533818
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification
- (2022) Carla Montironi et al. GUT
- Molecular and radio‐pathologic spectrum between hepatocellular carcinoma and intrahepatic cholangiocarcinoma
- (2022) Youngsic Jeon et al. HEPATOLOGY
- Clinical Significance of the Duality of Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma
- (2022) Tomoko Aoki et al. Cancers
- Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma
- (2022) Ryu Sasaki et al. Cancers
- Therapeutic efficacy of atezolizumab plus bevacizumab for hepatocellular carcinoma with WNT/β‑catenin signal activation
- (2022) Akifumi Kuwano et al. Oncology Letters
- The predictive value of tumor infiltrating leukocytes in Hepatocellular Carcinoma: A systematic review and meta-analysis
- (2021) Markus Bo Schoenberg et al. EJSO
- Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
- (2021) Chia-Lang Hsu et al. Liver Cancer
- Higher Enhancement Intrahepatic Nodules on the Hepatobiliary Phase of Gd-EOB-DTPA-Enhanced MRI as a Poor Responsive Marker of Anti-PD-1/PD-L1 Monotherapy for Unresectable Hepatocellular Carcinoma
- (2021) Tomoko Aoki et al. Liver Cancer
- The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma
- (2020) Shunjie Xia et al. EBioMedicine
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association between Genetic and Immunological Background of Hepatocellular Carcinoma and Expression of Programmed Cell Death-1
- (2020) Naoshi Nishida et al. Liver Cancer
- A novel scoring method based on RNA‐Seq immunograms describing individual cancer‐immunity interactions
- (2020) Yukari Kobayashi et al. CANCER SCIENCE
- Immune exclusion-Wnt/CTNNB1 class predicts resistance to immunotherapies in HCC
- (2019) Roser Pinyol et al. CLINICAL CANCER RESEARCH
- β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
- (2019) Marina Ruiz de Galarreta et al. Cancer Discovery
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next Generation Sequencing for Matching Patients to Targeted and Immune Therapies
- (2018) James J Harding et al. CLINICAL CANCER RESEARCH
- Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- Gadoxetic acid-enhanced magnetic resonance imaging reflects co-activation of β-catenin and hepatocyte nuclear factor 4α in hepatocellular carcinoma
- (2017) Azusa Kitao et al. HEPATOLOGY RESEARCH
- Genotype-phenotype correlation ofCTNNB1mutations reveals different ß-catenin activity associated with liver tumor progression
- (2016) Sandra Rebouissou et al. HEPATOLOGY
- Immunohistochemical molecular analysis indicates hepatocellular carcinoma subgroups that reflect tumor aggressiveness
- (2016) Hanako Tsujikawa et al. HUMAN PATHOLOGY
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Several immune escape patterns in non-Hodgkin's lymphomas
- (2015) Camille Laurent et al. OncoImmunology
- Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma
- (2014) Taro Yamashita et al. HEPATOLOGY
- OATP1B3 expression is strongly associated with Wnt/β-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma
- (2014) Akihisa Ueno et al. JOURNAL OF HEPATOLOGY
- A double-negative feedback loop between Wnt–β-catenin signaling and HNF4α regulates epithelial–mesenchymal transition in hepatocellular carcinoma
- (2013) Meng Yang et al. JOURNAL OF CELL SCIENCE
- SIFT web server: predicting effects of amino acid substitutions on proteins
- (2012) Ngak-Leng Sim et al. NUCLEIC ACIDS RESEARCH
- FoxM1: A Master Regulator of Tumor Metastasis
- (2011) P. Raychaudhuri et al. CANCER RESEARCH
- Hepatocellular Carcinoma: Hepatocyte-selective Enhancement at Gadoxetic Acid–enhanced MR Imaging—Correlation with Expression of Sinusoidal and Canalicular Transporters and Bile Accumulation
- (2010) Takahiro Tsuboyama et al. RADIOLOGY
- Convergence of Wnt Signaling on the HNF4α-Driven Transcription in Controlling Liver Zonation
- (2009) Marta Colletti et al. GASTROENTEROLOGY
- Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma
- (2009) Masato Narita et al. JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started